English中文

图片展示
图片展示

Live Now & The Future Direction


  • We are dedicated to providing high-efficiency and accurate individualized liquid biopsy products and services for cancer patients. We independently and fully own the intellectual property rights to advanced microfluidic chip technology and nucleic acid detection technology, which we utilize to provide comprehensive, high-precision, high-throughput and low-cost tumor liquid biopsy diagnostic solutions, services and products, including circulating tumor cell sorting chips and device, droplet digital PCR chips and devices, ctDNA and miRNA detection kit products for tumor liquid biopsy, etc. 

  • Cellomics also operates a "Medical Laboratory" and "CTC detection Laboratory". We have become a comprehensive service platform integrating clinical testing services, scientific research and development. We are committed to providing precise detection and personalized drug guidance technical services, and aim to be a key partner of clinical medical units and scientific research institutions, benefiting the large number of patients suffering from chronic diseases such as cancer, cardiovascular disease and diabetes.

  • Our future development / pipeline projects will combine with the latest international academic research to extend our products / services range to include the precise treatment and monitoring of a variety of major high-incidence chronic diseases.



About Cellomics


Cellomics International Limited (“Cellomics”) was incorporated in Hong Kong in 2018, and its Shenzhen subsidiary, Cellomics (Shenzhen) Co., Ltd. is located in Haikexing Hi-Tech Industrial Park in Pingshan, Shenzhen. Cellomics is a high-tech life-sciences enterprise which focuses on integrating research and development of tumor liquid biopsy technology, products transformation, and gene detection services.

  • We are dedicated to providing high-efficiency and accurate individualized liquid biopsy products and services for cancer patients. We independently and fully own the intellectual property rights to advanced microfluidic chip technology and nucleic acid detection technology, which we utilize to provide comprehensive, high-precision, high-throughput and low-cost tumor liquid biopsy diagnostic solutions, services and products, including circulating tumor cell sorting chips and device, droplet digital PCR chips and devices, ctDNA and miRNA detection kit products for tumor liquid biopsy, etc. 

  • Cellomics also operates a "Medical Laboratory" and "CTC detection Laboratory". We have become a comprehensive service platform integrating clinical testing services, scientific research and development. We are committed to providing precise detection and personalized drug guidance technical services, and aim to be a key partner of clinical medical units and scientific research institutions, benefiting the large number of patients suffering from chronic diseases such as cancer, cardiovascular disease and diabetes.

  • Our future development / pipeline projects will combine with the latest international academic research to extend our products / services range to include the precise treatment and monitoring of a variety of major high-incidence chronic diseases.

About


Company Profile

Enterprise Culture

Organizational Structure

Research Leader

Team Elegant Demeanour

Honor & Qualification

Investment & Cooperation

Laboratory

Solution

 

 

 

 

 

Product





News


Patient Story 

Research Results

Enterprise Dynamic

Latest Information


 WeChat Public Number



Copyright @ Cellomics All Rights Reserved  Email:info@cellomicsbio.com  Tel:+86-0755-28378001